Philip Mazzara Sells 10,000 Shares of Astera Labs (NASDAQ:ALAB) Stock

Astera Labs, Inc. (NASDAQ:ALAB) General Counsel Philip Mazzara sold 10,000 shares of the company’s stock in a transaction dated Wednesday, October 1st. The stock was sold at an average price of $192.16, for a total transaction of $1,921,600.00. Following the transaction, the general counsel owned 151,573 shares in the company, valued at $29,126,267.68. The trade was a 6.19% decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which can be accessed through the SEC website.

Philip Mazzara also recently made the following trade(s):

• On Thursday, August 28th, Philip Mazzara sold 10,000 shares of Astera Labs stock. The stock was sold at an average price of $188.70, for a total transaction of $1,887,000.00.
• On Monday, August 18th, Philip Mazzara sold 7,237 shares of Astera Labs stock. The stock was sold at an average price of $183.51, for a total transaction of $1,328,061.87.

Astera Labs Trading Down 4.2%

Shares of ALAB opened at $200.74 on Friday. The firm’s 50-day moving average is $189.83 and its two-hundred day moving average is $119.49. Astera Labs, Inc. has a twelve month low of $47.13 and a twelve month high of $262.90. The firm has a market capitalization of $33.37 billion, a P/E ratio of 358.46, a PEG ratio of 5.09 and a beta of 1.43.

Astera Labs (NASDAQ:ALAB) last issued its earnings results on Tuesday, August 5th. The company reported $0.44 earnings per share for the quarter, topping the consensus estimate of $0.33 by $0.11. The company had revenue of $191.93 million for the quarter, compared to analyst estimates of $172.46 million. Astera Labs had a net margin of 16.54% and a return on equity of 9.53%. The firm’s revenue for the quarter was up 149.5% compared to the same quarter last year. During the same period in the prior year, the business posted $0.13 earnings per share. Astera Labs has set its Q3 2025 guidance at 0.380-0.390 EPS. Analysts predict that Astera Labs, Inc. will post 0.34 EPS for the current year.

Wall Street Analysts Forecast Growth

Several analysts have recently commented on the stock. Cowen assumed coverage on shares of Astera Labs in a research report on Tuesday. They issued a “hold” rating on the stock. Morgan Stanley increased their price target on shares of Astera Labs from $155.00 to $200.00 and gave the company an “overweight” rating in a research report on Friday, August 29th. Jefferies Financial Group increased their price target on shares of Astera Labs from $95.00 to $130.00 and gave the company a “buy” rating in a research report on Tuesday, July 22nd. Citigroup increased their price target on shares of Astera Labs from $160.00 to $275.00 and gave the company a “buy” rating in a research report on Wednesday, September 17th. Finally, Barclays reiterated an “overweight” rating and issued a $155.00 price target (up from $75.00) on shares of Astera Labs in a research report on Thursday, August 7th. One analyst has rated the stock with a Strong Buy rating, fifteen have issued a Buy rating and seven have issued a Hold rating to the company’s stock. Based on data from MarketBeat, the company currently has a consensus rating of “Moderate Buy” and a consensus target price of $159.83.

Hedge Funds Weigh In On Astera Labs

Several hedge funds and other institutional investors have recently made changes to their positions in ALAB. Oliver Lagore Vanvalin Investment Group acquired a new position in shares of Astera Labs during the 2nd quarter valued at $29,000. Bernard Wealth Management Corp. acquired a new position in shares of Astera Labs during the 2nd quarter valued at $36,000. Clearstead Trust LLC lifted its holdings in shares of Astera Labs by 46,100.0% during the 2nd quarter. Clearstead Trust LLC now owns 462 shares of the company’s stock valued at $42,000 after acquiring an additional 461 shares in the last quarter. Advisors Asset Management Inc. lifted its holdings in shares of Astera Labs by 68.6% during the 2nd quarter. Advisors Asset Management Inc. now owns 477 shares of the company’s stock valued at $43,000 after acquiring an additional 194 shares in the last quarter. Finally, Manchester Capital Management LLC lifted its holdings in shares of Astera Labs by 141.5% during the 2nd quarter. Manchester Capital Management LLC now owns 483 shares of the company’s stock valued at $44,000 after acquiring an additional 283 shares in the last quarter. Institutional investors and hedge funds own 60.47% of the company’s stock.

About Astera Labs

Astera Labs, Inc designs, manufactures, and sells semiconductor-based connectivity solutions for cloud and AI infrastructure. Its Intelligent Connectivity Platform is comprised of a portfolio of data, network, and memory connectivity products, which are built on a unifying software-defined architecture that enables customers to deploy and operate high performance cloud and AI infrastructure at scale.